Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Stem Cells. 2011 Jan;29(1):57–66. doi: 10.1002/stem.550

Table 1.

Assessment of the therapeutic potential of HFSC to treat a mouse model of LSCD

Time
Post-transplantation
Number Goblet Cells
Peripheral Cornea
Vascularization Ocular Surface
Reconstruction
3d 3 0/3 (0%) 0/3 (0%) 3/3 (100%)
1 wk 5 1/5 (20%) 0/5 (0%) 4/5 (80%)
2 wk 8 1/8 (12.5%) 1/8 (12.5%) 7/8 (87.5%)
3 wk 7 2/7 (29%) 1/7 (14%) 5/7 (71%)
5 wk 5 1/5 (20%) 1/5 (20%) 4/5 (80%)
7 wk 3 1/3 (33%) 1/3 (33%) 2/3 (67%)